Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Hahn

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Oncology|January 26, 1999
A multidrug-resistant breast cancer cell line induced by weekly exposure to doxorubicinS M Hahn, A Russo, J A Cook, et al.
Cancer Research|May 29, 2000
Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ]T M Busch, S M Hahn, S M Evans, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1995
Influence of mixed venous PO2 and inspired O2 fraction on intrapulmonary shunt in patients with severe ARDSR Rossaint, S M Hahn, D Pappert, et al.
American Journal of Clinical Oncology|October 5, 2001
Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferationS M Evans, S M Hahn, D P Magarelli, et al.
Archives of Biochemistry and Biophysics|July 1, 1991
Mn(III)-desferrioxamine superoxide dismutase-mimic: alternative modes of actionS M Hahn, C M Krishna, A Samuni, et al.
Cancer Research|September 15, 1999
Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft modelB W Engbrecht, C Menon, A V Kachur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinomaT J Robnett, M Machtay, J P Stevenson, et al.
The Journal of Clinical Investigation|May 1, 1991
Nitroxide stable radicals protect beating cardiomyocytes against oxidative damageA Samuni, D Winkelsberg, A Pinson, et al.
Free Radical Biology & Medicine|May 10, 2000
Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotectorS M Hahn, M C Krishna, A M DeLuca, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
In vivo radioprotection and effects on blood pressure of the stable free radical nitroxidesS M Hahn, A M DeLuca, D Coffin, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Oncology|January 26, 1999
A multidrug-resistant breast cancer cell line induced by weekly exposure to doxorubicinS M Hahn, A Russo, J A Cook, et al.
Cancer Research|May 29, 2000
Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ]T M Busch, S M Hahn, S M Evans, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1995
Influence of mixed venous PO2 and inspired O2 fraction on intrapulmonary shunt in patients with severe ARDSR Rossaint, S M Hahn, D Pappert, et al.
American Journal of Clinical Oncology|October 5, 2001
Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferationS M Evans, S M Hahn, D P Magarelli, et al.
Archives of Biochemistry and Biophysics|July 1, 1991
Mn(III)-desferrioxamine superoxide dismutase-mimic: alternative modes of actionS M Hahn, C M Krishna, A Samuni, et al.
Cancer Research|September 15, 1999
Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft modelB W Engbrecht, C Menon, A V Kachur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinomaT J Robnett, M Machtay, J P Stevenson, et al.
The Journal of Clinical Investigation|May 1, 1991
Nitroxide stable radicals protect beating cardiomyocytes against oxidative damageA Samuni, D Winkelsberg, A Pinson, et al.
Free Radical Biology & Medicine|May 10, 2000
Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotectorS M Hahn, M C Krishna, A M DeLuca, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
In vivo radioprotection and effects on blood pressure of the stable free radical nitroxidesS M Hahn, A M DeLuca, D Coffin, et al.
Pageof 6